We are undertaking a major research study into PSA and Free to Total scoring working alongside the University of Manchester. This important research commenced in January 2021, with the aim of finishing in two to three years. We hope this research will help persuade the Health Authorities to implement a National Prostate Cancer Screening Programme for all men in the UK.If you would like to help us achieve this, we would ask you to participate by completing the questionnaire by clicking this link...

Tracer is injected into the bloodstream and lights up metastatic prostate cancer cells during PET scanHealthDay FRIDAY, May 28, 2021 (HealthDay News) -- A new imaging agent that detects prostate cancer that has spread to other parts of the body has been approved by the U.S. Food and Drug Administration.The tracer will help doctors find metastatic prostate cancer cells that are difficult to detect with traditional imaging methods, Michael Morris, M.D., a medical oncologist at Memorial Sloan Kette...

European UrologyTAKE-HOME MESSAGEThis study presented 2-year follow-up data of a randomised trial comparing prostate artery embolisation (PAE) with transurethral resection of the prostate (TURP) among men with refractory symptoms secondary to benign prostatic hyperplasia with prostate sizes 25 to 80 cc, International Prostate Symptoms Score (IPSS) >7, quality-of-life score >2, and Qmax <12 mL/s. In all, 103 patients were initially randomised, 51 to PAE and 52 to TURP, with 34 (PAE) and 47 (TURP)...

NEWS RELEASE 26-APR-2021Test could reduce invasive biopsiesUNIVERSITY OF EAST ANGLIANew prostate cancer urine test shows how aggressive disease is and could reduce invasive biopsiesResearchers from the University of East Anglia have developed a new urine test for prostate cancer which also shows how aggressive the disease is.A new study published today shows how an experimental new test called 'ExoGrail' has the potential to revolutionise how patients with suspected prostate cancer are risk-asse...

We are delighted to announce that the Research Project recently launched in conjunction with Manchester University is being sponsored for 2021 by GenesisCare.This sponsorship will help support us to recruit as many men as possible to the project from tests either carried out by us or our partners, over the past 10 years.WHO ARE GENESISCARE?GenesisCare is the UK’s leading independent provider of advanced and innovative cancer diagnostics, chemotherapy, radiotherapy and Theranostics. It currently...

GFCT JOINS GROUNDBREAKING RAPID MRI PATHWAY PROJECT!We are absolutely delighted we have now joined the above project headed by Professor Hashim U Ahmed at Imperial College.The programme aims to offer a fast-track prostate cancer diagnostic pathway using high quality MRI scanning techniques. It has so far achieved very encouraging results with a 40 to 50% reduction in the need for biopsy following a raised PSA score.Moreover, where biopsies are required, they take the form of the much safer trans...

To the Graham Fulford Charitable Trust I am involved with a local Prostate Cancer Support Group and as a P.C.patient myself I had a need to order one of your 'Self Testing' PSA sample kits.I required a kit quickly as I had an appointment with a Consultant on a Monday morning, I quickly ordered a self-test kit (on a Thursday) hoping that it would arrive in time for me to do the sample, the sample duly arrived the day after - Friday morning!My next thought was, would I get the sample back in time ...

Dear SirsThis letter is to thank you for my being made aware of this disease and as it was caught early, I am able to write this letter.When requesting a routine PSA test in 2017 I found that my GP was not much help and I found that I was queried why I had asked for a PSA test with no symptoms present and he warned me about the risk of treatment outweighing the benefits of early misdiagnosis and procedures due to the test.  I persevered and had the test done, citing the blood test taken at your ...

An article written by Laura Donnelly recently in the Daily Telegraph.Please click on the link for more information...https://digitaleditions.telegraph.co.uk/data/537/reader/reader.html?#!preferred/0/package/537/pub/537/page/31/article/150677

Published in UrologyJournal Scan / Research · February 27, 2021European Urology TAKE-HOME MESSAGEThis study prospectively followed more than 40,000 men in the Health Professionals Follow-up Study (1986–2014) to evaluate the impact of diet on prostate cancer. In multivariable-adjusted models, the authors found that there was a 7% higher risk of advanced prostate cancer and a 9% higher risk of fatal prostate cancer in the hyperinsulinemic diet. When stratified by age, the hyperinsulinemic diet wa...